Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cabaletta Bio, Inc.CABA · Entity 5418 | General Counsel | March 01, 2021 | March 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cabaletta Bio, Inc.
Report date March 01, 2021 · Filed March 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.47 · Expires 2031-02-28 | Direct | 64,500 |
Reported balance
After 2021-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-01 · Grant · Acquired 64,500 · Balance 64,500 F1: This option vests over four years, with 25% vesting on March 1, 2022 and the remaining shares vesting in 12 equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests over four years, with 25% vesting on March 1, 2022 and the remaining shares vesting in 12 equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 3, 2021 02:48 UTC | Cabaletta Bio, Inc. CABA · Entity 5418 | GrantStock Option (Right to Buy) · Derivative | 64,500 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0000899243-21-009238 · doc4.xml · derivative · entry 1 Stalter John Brian · CIK 0001790556 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,500 Underlying: Common Stock · 64,500 shares Expires 2031-02-28 F1 · derivative.exercise_date: This option vests over four years, with 25% vesting on March 1, 2022 and the remaining shares vesting in 12 equal quarterly installments thereafter. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:18 UTC | Cabaletta Bio, Inc. CABA · Entity 5418 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $12.01 | $0.00 |
DisclosureSEC source: 0000899243-20-025326 · doc4.xml · derivative · entry 1 Stalter John Brian · CIK 0001790556 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-09-13 F1 · derivative.exercise_date: This option vests over four years, with 25% vesting on September 14, 2021, and the remaining shares vesting in 12 equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.